TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
AMRN

Amarin Corporation PLC

Healthcare · Drug Manufacturers - General

12.10$ -2.1% vs. previous close Closing price · As of: Oct 5, 2026

Statements

Income Statement

Amarin Corporation PLC (AMRN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 42 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement AMRN
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
33 39 35 45 47 54 44 53 55 77 73 101 112 143 155 135 156 167 142 154 142 144 95 94 90 90 86 80 66 75 57 68 42 62 42 73 50 49 45 42 186
8.5 10 8.2 11 12 13 11 13 14 17 17 23 25 31 35 29 33 35 28 32 30 31 22 51 27 27 38 37 36 30 25 26 26 72 17 22 27 27 27 27 109
24 29 26 34 35 40 33 40 42 60 56 78 87 113 120 107 123 132 114 122 112 114 72 44 63 64 48 43 30 45 32 42 16 -9.6 25 50 22 22 18 15 77
13 10 11 14 11 12 12 18 14 12 7.2 7.1 8.9 11 10 10.0 10 8.5 9.4 6.4 7.8 5.8 10 9.4 5.8 5.2 5.7 5.6 5.1 5.8 5.6 4.0 4.5 6.0 5.3 4.9 4.2 4.7 4.7 4.8 18
22 26 29 27 27 29 34 44 39 63 17 21 21 96 31 28 27 27 39 34 35 33 28 34 26 30 27 19 21 21 19 18 18 17 20 24 14 16 17 19 67
40 41 45 45 44 48 55 72 64 92 79 81 91 107 144 102 130 125 115 114 125 98 101 106 68 73 65 67 51 50 45 43 41 43 42 66 33 25 26 27 111
-15 -13 -19 -11 -8.4 -7.2 -22 -32 -22 -32 -23 -2.5 -4.5 5.5 -24 4.2 -6.9 7.2 -1.3 8.8 -13 16 -28 -63 -5.1 -9.6 -17 -24 -21 -4.8 -14 -0.5 -25 -53 -17 -16 -11 -2.3 -8.0 -12 -33
5.1 2.3 2.4 2.5 2.4 2.4 2.3 2.3 2.3 2.0 1.8 1.7 1.6 1.4 1.2 0.8 0.5 0.2 0.1 0.0 0.4 0.0 0.2 0.3 0.8 0.0 1.1 – – 0.0 – – – 0.0 – – – 0.0 – – –
-17 -14 -20 -14 -11 -9.5 -24 -34 -24 -34 -24 -1.8 -3.5 7.2 -23 4.4 -6.4 7.6 -1.0 8.9 -13 16 -28 -65 -3.9 -6.8 -14 -18 -19 -2.4 -8.7 2.9 -22 -50 -14 -13 -8.1 -0.9 -8.7 -7.9 -26
-1.0 12 2.4 2.2 2.4 13 2.2 1.9 2.2 0.1 1.7 1.7 -1.1 0.2 -2.4 -0.3 0.4 2.7 0.6 1.1 0.2 1.7 3.2 5.2 1.3 -7.6 2.0 -0.4 0.5 3.3 1.3 1.4 3.6 -1.3 2.1 0.7 -0.4 0.4 1.8 -0.2 1.6
-16 -27 -21 -14 -11 -22 -24 -34 -24 -34 -24 -1.8 -3.5 7.1 -21 4.4 -6.8 4.9 -1.6 7.8 -13 15 -32 -70 -5.1 0.9 -16 -18 -19 -5.8 -10.0 1.5 -25 -49 -16 -14 -7.7 -1.2 -11 -7.7 -27
-12 -13 -18 -11 -8.2 -6.8 -22 -32 -22 -31 -22 0.1 -1.6 9.0 -21 5.7 -5.5 8.3 -0.8 9.7 1.8 17 -28 -52 -0.9 -20 -14 -13 -20 -0.9 -7.9 3.7 -21 -37 -13 7.5 -0.8 -0.1 -7.4 -11 -20

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?